Overexpression of SOX2 has been associated with copy number amplification and promoter overexpression in multiple malignancies such as breast carcinomas, lung cancer tissues including squamous cell carcinoma and adenocarcinomas, with high levels of SOX2 expression correlating with decreased patient survival [11]. Here, SOX2 is linked to squamous cell carcinoma.